Cortechs.ai and Subtle Medical Partner to Deliver Faster MRI with Standardized Quantitative Neuroimaging

COVINGTON, Ky., Nov. 10, 2026 — Cortechs.ai, the global leader in quantitative neuroimaging, and Subtle Medical, a leader in AI-powered medical imaging enhancement, today announced a strategic partnership to integrate Cortechs.ai's NeuroQuant® portfolio with Subtle Medical's MRI enhancement solutions, bringing advanced image processing and quantitative neuroimaging together in a single workflow.

As imaging providers face increasing demand for MRI services, the need for efficient scanning and reliable quantitative measurements continues to grow. This partnership combines Subtle Medical's AI-powered MRI enhancement and alignment technologies with Cortechs.ai's automated brain volumetry and lesion quantification solutions to support faster imaging protocols, streamlined workflows, and consistent quantitative analysis across longitudinal studies.

"Reliable quantitative neuroimaging is essential for supporting clinical decision-making and monitoring changes over time," said Kyle Frye, Chief Executive Officer of Cortechs.ai. "By combining our NeuroQuant portfolio with Subtle Medical's advanced MRI enhancement technologies, we are bringing together faster imaging and objective quantitative analysis in a streamlined workflow that supports both imaging providers and the clinicians who rely on their results."

Subtle Medical's FDA-cleared SubtleHD™ uses deep learning to enhance MR image quality while enabling scan time reductions of up to 80% in certain sequences. Its SubtleALIGN™ software automatically aligns brain MR images to a standardized anatomical position, helping reduce variability across longitudinal studies. Together with Cortechs.ai's NeuroQuant®, NeuroQuant® MS, and NeuroQuant® Lesion Surveillance, these technologies support automated segmentation and volumetric analysis of brain structures and lesions, providing clinicians with objective quantitative data to support clinical assessment and longitudinal monitoring.

"Imaging providers don't need more point solutions. They need AI that works together and makes every scan more valuable," said Josh Gurewitz, Chief Commercial Officer of Subtle Medical. "Partnering with Cortechs.ai lets us pair faster, higher-quality MRI with trusted quantitative neuroimaging, delivered seamlessly into PACS. It expands what our customers can offer referring physicians, from neurology to MS care, without adding hardware or complexity. We're excited to bring this to market together and to keep expanding what a unified AI layer can do."

Through the partnership, Cortechs.ai applications will be integrated into Subtle Medical's vendor-neutral imaging platform. Imaging studies will be de-identified at the customer site before processing, with results returned directly to PACS alongside enhanced images. The companies will also expand access to their respective MRI solutions through joint commercial efforts.

Additionally, Cortechs.ai and Subtle Medical will jointly evaluate the impact of combining AI-powered image enhancement and alignment with automated volumetric analysis on measurement consistency across scanners and longitudinal studies. Findings from this collaboration are expected to be shared in a joint clinical white paper.

The companies will showcase their partnership at RSNA 2026, taking place November 29 through December 3 in Chicago. Attendees are invited to visit Cortechs.ai at Booth 5107 and Subtle Medical at Booth 5104 to learn more about the collaboration and its potential to advance MRI efficiency and quantitative neuroimaging.

Media Contact:

Anna Menyhart-Borroni

Head of Global Marketing

 [email protected]

SOURCE Cortechs.ai